Ligand Pharmaceuticals, Inc. - Class B (LGND) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

Data del prossimo reportMay 2, 2024

Stimato per Q1 24:$0.68

Cambiamenti implicati per il Q4 23:-13.92%

Cambiamenti implicati per il Q1 22:+353.33%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q4 23	Feb 27, 2024	$0.79 / $0.24	$0.55 / 229.17%
Q3 23	Nov 8, 2023	$0.71 / $0.36	$0.35 / 97.22%
Q2 23	Aug 8, 2023	$1.1 / $0.39	$0.71 / 182.05%
Q1 23	May 4, 2023	$1.96 / $0.58	$1.38 / 237.93%
Q4 22	Feb 22, 2023	$-0.26 / $0.71	$-0.97 / -136.62%
Q3 22	Nov 7, 2022	$-0.2 / $0.09	$-0.29 / -322.22%
Q2 22	Aug 8, 2022	$-0.14 / $0.12	$-0.26 / -216.67%
Q1 22	May 4, 2022	$0.15 / $0.19	$-0.04 / -21.05%

Fornitori di Dati: Xignite Logo